TY - JOUR
T1 - Evaluation of a Webinar for Pharmacists Learning Basic Clinical- Oncology during COVID-19 Pandemic in Japan
AU - Terazono, Hideyuki
AU - Tsuchiya, Masami
AU - Maki, Yosuke
AU - Yoshikawa, Naoki
AU - Kawahara, Yosuke
AU - Nishimura, Keiko
AU - Shinohara, Keisuke
AU - Ogawa, Daisuke
AU - Mori, Riho
AU - Iwamoto, Yoshihiro
AU - Itagaki, Fumio
AU - Masuko, Hiroyuki
AU - Yonemura, Masahito
AU - Uchida, Mayako
N1 - Publisher Copyright:
© 2022 Pharmaceutical Society of Japan. All rights reserved.
PY - 2022/7
Y1 - 2022/7
N2 - It is essential for oncology pharmacists to update their knowledge, skills, and ethical attitudes. The Japanese Society of Pharmaceutical Oncology is an academic society for healthcare professionals involved in cancer treatment. It has conducted in-person seminars every year to cultivate the knowledge necessary for practicing advanced cancer medicine. Owing to the coronavirus disease (COVID-19) pandemic, the society was obligated to conduct a web-based seminar this year. A questionnaire survey was conducted before and after the webinar to explain how it works and to assess the learning attitudes of beginner and moderately skilled pharmacists in the field of oncology. Questionnaire surveys were conducted with the participants before and after watching the webinar. The questionnaires sought to determine participants' perspectives on the webinar and their knowledge of the seven modules. Of the 1756 webinar attendees, 1661 (94.6%) answered the pre-webinar survey and 1586 (90.3%) answered the post-webinar survey. Results indicate that the median post-webinar knowledge score was significantly higher than the median pre-webinar score (p < 0.001) in all modules. Principal component analysis of the degree of knowledge of seven modules revealed that the improved score group consisted of those from younger age groups, with less experience as pharmacists, nonsociety members, and those with less experience in past society seminars. Moreover, the web-based seminar provided a uniform learning effect throughout the country without distinguishing between urban and rural learners. The web-based educational program was an acceptable educational tool for Japanese oncology pharmacists.
AB - It is essential for oncology pharmacists to update their knowledge, skills, and ethical attitudes. The Japanese Society of Pharmaceutical Oncology is an academic society for healthcare professionals involved in cancer treatment. It has conducted in-person seminars every year to cultivate the knowledge necessary for practicing advanced cancer medicine. Owing to the coronavirus disease (COVID-19) pandemic, the society was obligated to conduct a web-based seminar this year. A questionnaire survey was conducted before and after the webinar to explain how it works and to assess the learning attitudes of beginner and moderately skilled pharmacists in the field of oncology. Questionnaire surveys were conducted with the participants before and after watching the webinar. The questionnaires sought to determine participants' perspectives on the webinar and their knowledge of the seven modules. Of the 1756 webinar attendees, 1661 (94.6%) answered the pre-webinar survey and 1586 (90.3%) answered the post-webinar survey. Results indicate that the median post-webinar knowledge score was significantly higher than the median pre-webinar score (p < 0.001) in all modules. Principal component analysis of the degree of knowledge of seven modules revealed that the improved score group consisted of those from younger age groups, with less experience as pharmacists, nonsociety members, and those with less experience in past society seminars. Moreover, the web-based seminar provided a uniform learning effect throughout the country without distinguishing between urban and rural learners. The web-based educational program was an acceptable educational tool for Japanese oncology pharmacists.
KW - coronavirus disease (COVID-19)
KW - oncology pharmacist
KW - questionnaire survey
KW - webbased educational program
KW - webinar
UR - http://www.scopus.com/inward/record.url?scp=85133217035&partnerID=8YFLogxK
U2 - 10.1248/bpb.b21-00844
DO - 10.1248/bpb.b21-00844
M3 - 記事
C2 - 35786594
AN - SCOPUS:85133217035
SN - 0918-6158
VL - 45
SP - 856
EP - 862
JO - Biological and Pharmaceutical Bulletin
JF - Biological and Pharmaceutical Bulletin
IS - 7
ER -